Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Understanding the timing of transmission dynamics of Covid-19 is crucial for optimising public health interventions and reducing the burden on communities.

Man wearing a face mask on public transport

Knowledge of the period of high infectiousness is particularly useful in the context of contact tracing as it allows to identify the contacts at highest risk of having contracted the disease, maximising the number of infectious individuals in quarantine while minimising the number of people unnecessarily isolated. The preprint paper 'The timing of Covid-19 transmission', published in MedRxiv, is centered around the question “When is someone who has been infected with COVID-19 most likely to infect others?”.

The analysis focuses on individuals who eventually develop symptoms, studying 191 transmission pairs from multiple data sets. Each transmission pair includes an index case and a secondary case, infected by the index case. Datasets were selected because they contained information not only about the dates of onset of symptoms for both cases, but also intervals of exposure for the index and/or secondary case. For these pairs and individuals, four key timings related to Covid-19 transmission were known or inferred.

Read more about the key findings in a blog on the Coronavirus Fraser Group website. There is also in a media update on the Big Data Institute website

Similar stories

New form of gift wrap drives male reproductive success

General Research

A study from the Department of Physiology, Anatomy and Genetics (DPAG) has identified a new communication mechanism that ensures the transfer of a complex mix of signals and nutrients required for successful reproduction between males and females.

PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19

Coronavirus COVID-19 General Research

In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for hospital admission. The trial is one of three national platform trials for COVID-19 treatments, and complements the RECOVERY and REMAP-CAP trials that focus on hospitalised patients.

Early animal studies yield promising results for new potential COVID-19 vaccine

Coronavirus COVID-19 General Research

Studies carried out in the MRC Human Immunology Unit (MRC HIU) in collaboration with the Pirbright Institute have shown that a new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this type of vaccine is not a competitor for the first wave of vaccines, it is hoped that it will be useful as a standalone vaccine or as a booster for individuals primed with a different COVID-19 vaccine.

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.